Organogenesis Holdings (ORGO) Other Working Capital Changes (2017 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly Other Working Capital Changes of $1.7 million in Q1 2026, up 153.13% quarter-over-quarter from -$3.1 million in Q4 2025, and down 67.69% on a YoY basis from $5.1 million in Q1 2025.
Organogenesis Holdings (ORGO) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 67.69% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at -$3.3 million (down 197.86% YoY), while the FY2025 annual figure was $183000.0, down 92.82% from the prior year.
- Other Working Capital Changes was $1.7 million for Q1 2026 at Organogenesis Holdings, up from -$3.1 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $7.8 million in Q2 2025 to a low of -$9.6 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged $782075.0 across 5 years, with a median of $379000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes sank 482.82% in 2023, then jumped 11103.72% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $379000.0 in 2022, then jumped by 1383.91% to $5.6 million in 2023, then slumped by 126.72% to -$1.5 million in 2024, then tumbled by 107.25% to -$3.1 million in 2025, then surged by 153.13% to $1.7 million in 2026.
- The last three Other Working Capital Changes figures came in at $1.7 million (Q1 2026), -$3.1 million (Q4 2025), and -$9.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | -3.12 Mn |
| Dec 31, 2025 | -3.12 Mn |
| Sep 30, 2025 | -9.64 Mn |
| Sep 30, 2025 | -9.64 Mn |
| Jun 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | 7.82 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2024 | 3.62 Mn |
| Sep 30, 2024 | 3.62 Mn |
| Jun 30, 2024 | -3.88 Mn |
| Jun 30, 2024 | -3.88 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 5.62 Mn |
| Dec 31, 2023 | 5.62 Mn |